Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Organ Denervation to RedUce Sympathetic Drive, Multi-Center, Prospective Feasibility Study - The MODUS ON MED Study

NCT04917393 is registered in ClinicalTrials.gov with Metavention as lead sponsor.

NCT NCT04917393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04917393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Organ Denervation to RedUce Sympathetic Drive, Multi-Center, Prospective Feasibility Study - The MODUS ON MED Study
Lead sponsor
Metavention
Phase
Not applicable
Overall status
Unknown status
Start date
September 13, 2021
Completion date
October 1, 2023
Enrollment
45 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, metabolic syndrome, type 2 diabetes